These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7109011)

  • 21. "Superactive" charcoal adsorbs drugs as fast as standard antidotal charcoal.
    Cooney DO; Kane RP
    Clin Toxicol; 1980 Mar; 16(1):123-5. PubMed ID: 7389278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saline cathartics and the adsorptive capacity of activated charcoal for aspirin.
    Czajka PA; Konrad JD
    Ann Emerg Med; 1986 May; 15(5):548-51. PubMed ID: 3963535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated Charcoal and Bicarbonate for Aspirin Toxicity: a Retrospective Series.
    Isoardi KZ; Henry C; Harris K; Isbister GK
    J Med Toxicol; 2022 Jan; 18(1):30-37. PubMed ID: 34845647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
    Laine K; Kivistö KT; Laakso I; Neuvonen PJ
    Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated charcoal in oral ethanol absorption: lack of effect in humans.
    Minocha A; Herold DA; Barth JT; Gideon DA; Spyker DA
    J Toxicol Clin Toxicol; 1986; 24(3):225-34. PubMed ID: 3723647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capacity of two forms of activated charcoal to adsorb nefopam in vitro and to reduce its toxicity in vivo.
    Neuvonen PJ; Kannisto H; Lankinen S
    J Toxicol Clin Toxicol; 1983-1984; 21(3):333-42. PubMed ID: 6676475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of magnesium citrate on the in vitro adsorption of aspirin by activated charcoal.
    Lapierre G; Algozzine G; Doering PL
    Clin Toxicol; 1981 Jul; 18(7):793-6. PubMed ID: 7307462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of type and amount of carboxymethylcellulose on in vitro salicylate adsorption by activated charcoal.
    Cooney DO
    J Toxicol Clin Toxicol; 1982 Jun; 19(4):367-76. PubMed ID: 7143523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful therapy of salicylate poisoning using glycine and activated charcoal].
    Mühlebach S; Steger P; Conen D; Wyss PA
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2127-9. PubMed ID: 8999500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined paracetamol and amitriptyline adsorption to activated charcoal.
    Hoegberg LC; Groenlykke TB; Abildtrup U; Angelo HR
    Clin Toxicol (Phila); 2010 Nov; 48(9):898-903. PubMed ID: 20932101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saccharin sodium as a potential sweetener for antidotal charcoal.
    Cooney DO
    Am J Hosp Pharm; 1977 Dec; 34(12):1342-4. PubMed ID: 596384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro adsorption of tilidine HCl by activated charcoal.
    Cordonnier JA; Van den Heede MA; Heyndrickx AM
    J Toxicol Clin Toxicol; 1986-1987; 24(6):503-17. PubMed ID: 3573124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of activated charcoal and gastric lavage in the prevention of aspirin absorption.
    Burton BT; Bayer MJ; Barron L; Aitchison JP
    J Emerg Med; 1984; 1(5):411-6. PubMed ID: 6599950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal.
    Rosenberg PJ; Livingstone DJ; McLellan BA
    Ann Emerg Med; 1988 Jul; 17(7):681-3. PubMed ID: 3382069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidotal efficacy of activated charcoal in presence of jam, starch and milk.
    De Neve R
    Am J Hosp Pharm; 1976 Sep; 33(9):965-6. PubMed ID: 990044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.